{"id":"1794617011208-news-segment","slug":"biotech-ipo-pops-67-on-nasdaq-debut","title":"Biotech IPO pops 67% on Nasdaq debut","summary":"Windward Bio, a Basel-based biotech developing antibody medicines for respiratory and dermatologic diseases, priced its Nasdaq IPO at $17 per share — the midpoint of its $16–$18 range — raising $175 million. Shares opened at $18.35 and closed at $28.50, a first-day gain of 67.65%, giving the company a market capitalization of about $1.07 billion. Sanofi agreed to buy $50 million of shares in a concurrent private placement, bringing total gross proceeds to $225 million.\n\nThe IPO succeeded despite a broader market struggling with an AI-driven tech selloff and higher-for-longer interest rates. Biotech IPOs have been a bright spot, with more than half a dozen biotech firms going public in New York since September, partly due to policy shifts under the Trump administration and changes at the FDA. Windward's CEO, Luca Santarelli, previously led VectivBio and Therachon, which sold for $1.2 billion and $810 million respectively.\n\nWindward Bio priced its IPO at $17, opened at $18.35 on Nasdaq, and closed at $28.50 — up 67.65% — giving it a market value of about $1.07 billion on its debut.","publishedAt":"2026-11-14T00:43:31.208Z","channel":{"id":"news","name":"Oncast News","language":"en"},"show":"News Tonight","verification":{"status":"verified","leadVerdict":"TRUE","notes":"TRUE: Windward Bio priced its IPO at $17, opened at $18.35 on Nasdaq, and closed at $28.50 — up 67.65% — giving it a market value of about $1.07 billion on its debut.\nSource: Reuters NAMES: WWB = Windward Bio's Nasdaq ticker; Novo Holdings = Danish investment firm that controls Novo Nordisk. (https://x.com/Reuters/status/2121402747442339885)","claims":[{"verdict":"TRUE","summary":"Windward Bio priced its IPO at $17, opened at $18.35 on Nasdaq, and closed at $28.50 — up 67.65% — giving it a market value of about $1.07 billion on its debut.","sourceName":"Reuters NAMES: WWB = Windward Bio's Nasdaq ticker; Novo Holdings = Danish investment firm that controls Novo Nordisk.","sourceUrl":"https://x.com/Reuters/status/2121402747442339885","claim":"Novo Holdings-backed Windward Bio valued at $1 billion as shares rise in Nasdaq debut https://t.co/WxWeNsJOSj","author":"@Reuters"}]},"sources":[{"url":"https://x.com/Reuters/status/2121402747442339885","name":"Reuters NAMES: WWB = Windward Bio's Nasdaq ticker; Novo Holdings = Danish investment firm that controls Novo Nordisk.","kind":"x","verdict":"TRUE","author":"@Reuters"}],"url":"https://oncast.fm/story/1794617011208-news-segment-biotech-ipo-pops-67-on-nasdaq-debut","listenUrl":"https://oncast.fm/c/news","attribution":{"publisher":"Oncast","site":"https://oncast.fm","url":"https://oncast.fm/story/1794617011208-news-segment-biotech-ipo-pops-67-on-nasdaq-debut","cite":"Cite https://oncast.fm/story/1794617011208-news-segment-biotech-ipo-pops-67-on-nasdaq-debut and the original source links. Fact-check by Oncast (oncast.fm)."},"hostsSaid":[{"host":"Bella","text":"A biotech company just went public and popped sixty-seven percent on day one."},{"host":"Brian","text":"Windward Bio. Swiss outfit, antibody medicines. Priced at seventeen, closed at twenty-eight fifty."},{"host":"Bella","text":"That's a billion-dollar valuation on the first day. Novo Holdings is behind it — the same Danish firm that controls Novo Nordisk."},{"host":"Brian","text":"And Sanofi bought fifty million in a private placement. So the smart money's in."},{"host":"Bella","text":"Smart money's in everything these days. But here's what's interesting — this happened while the broader market is getting hammered by the AI selloff."},{"host":"Brian","text":"Right, and biotech IPOs have been a bright spot. More than half a dozen since September."},{"host":"Bella","text":"Why? What's changed?"},{"host":"Brian","text":"Policy shifts under Trump, changes at the FDA. The IPO window for biotech is open."},{"host":"Bella","text":"I'll take it. A Swiss company listing on Nasdaq, raising a hundred seventy-five million, and it moonshots. That's a real story."},{"host":"Brian","text":"The CEO, Luca Santarelli, has done this before. VectivBio sold for one point two billion. Therachon for eight hundred ten million."},{"host":"Bella","text":"So he's a serial founder who knows how to exit. That's the kind of guy you want running a public company."},{"host":"Brian","text":"Or the kind of guy who knows how to sell. But the stock closed at twenty-eight fifty, so the market's buying what he's selling."},{"host":"Bella","text":"Speaking of markets, here's a different kind of story. Al Jazeera is reporting Ukraine claims a record three thousand Russian casualties in one day."},{"host":"Brian","text":"That's a staggering number. And it's a claim — no independent confirmation yet."},{"host":"Bella","text":"Right. Ukraine's been putting out big casualty numbers, and Russia does the same. The fog of war is real."},{"host":"Brian","text":"But if it's even close to true, that's a catastrophic day for Russian forces. Three thousand in a single day."},{"host":"Bella","text":"And it comes as the war drags on with no end in sight. Both sides are grinding."},{"host":"Brian","text":"The question is whether Ukraine can sustain this. They're outmanned, outgunned, and now they're claiming record kills."},{"host":"Bella","text":"I think the bigger question is what Russia does next. If they're losing three thousand a day, that's unsustainable."},{"host":"Brian","text":"But we've been saying that for two years. Russia keeps throwing bodies at it."},{"host":"Bella","text":"And that's exactly the point. They can absorb losses that would break a Western army."},{"host":"Brian","text":"So what's the endgame? Ukraine claims a record day, and the war just... continues?"},{"host":"Bella","text":"That's the tragedy. No breakthrough, no negotiation, just a higher body count."},{"host":"Brian","text":"Meanwhile, Al Jazeera also has a piece asking if Netanyahu can strike Iran before he leaves office."},{"host":"Bella","text":"That's speculative analysis, not news. But it's a real question hanging over the region."},{"host":"Brian","text":"Legally, his caretaker government can still go to war, some analysts argue."},{"host":"Bella","text":"But politically? It would inflame domestic divisions. Israel's already fractured."},{"host":"Brian","text":"I think he'd do it if he thought it was necessary. Netanyahu's never been shy about using force."},{"host":"Bella","text":"And Iran's nuclear program isn't going away. The clock's ticking."},{"host":"Brian","text":"But a strike now, with a caretaker government, would be seen as a desperate move."},{"host":"Bella","text":"Or a decisive one. Depends on your view of Netanyahu."},{"host":"Brian","text":"Here's one that'll start a fight. Al Jazeera reports a baby died from the cold in Gaza, and fifty-three countries are urging Israel to allow aid in."},{"host":"Bella","text":"That's a heartbreaking story. And again, it's a claim from Al Jazeera — no independent confirmation."},{"host":"Brian","text":"But the humanitarian situation in Gaza is dire. That's not in dispute."},{"host":"Bella","text":"No, it's not. The question is what Israel does about it. Fifty-three countries are calling for aid access."},{"host":"Brian","text":"And Israel says it's allowing aid in, but the distribution is the problem. Israel says Hamas steals it and sells it, though that's unverified."},{"host":"Bella","text":"That's the Israeli argument. But a baby freezing to death? That's a failure on every level."},{"host":"Brian","text":"I'm not excusing it. I'm saying the blame isn't all on one side. Hamas started this war, and they're still holding hostages."},{"host":"Bella","text":"And Israel has a right to defend itself. But the civilian toll is enormous, and the world is watching."},{"host":"Brian","text":"So what's the answer? Let Hamas rearm? Let them keep firing rockets?"},{"host":"Bella","text":"No, but there has to be a way to get aid in without letting weapons through. That's the challenge."},{"host":"Brian","text":"And it's a challenge Israel has failed at, repeatedly. That's the honest truth."},{"host":"Bella","text":"I'll give you that. The aid situation is a mess, and innocent people are dying."},{"host":"Brian","text":"Different world entirely: a post on X from Latimer Alder says world leaders are skipping the climate conference in Turkey."},{"host":"Bella","text":"The thirty-first annual climate gabfest, as he calls it. No Xi, no Modi, no Trump, no Macron."},{"host":"Brian","text":"And no Merz, no Carney. Just the British PM for three hours, apparently."},{"host":"Bella","text":"That's unverified, by the way. We couldn't confirm the no-show list."},{"host":"Brian","text":"But the point stands. Climate summits have lost their star power."},{"host":"Bella","text":"Because they've become talking shops. Lots of pledges, little action."},{"host":"Brian","text":"And the leaders who matter are busy with wars, economies, and elections."},{"host":"Bella","text":"I think that's the real story. Climate is no longer the top priority for most governments."},{"host":"Brian","text":"Which is either a tragedy or a reality check, depending on your politics."},{"host":"Bella","text":"I'll take reality check. The world has bigger problems right now."},{"host":"Brian","text":"And that's the show. We'll be back with more after this."}]}